Page last updated: 2024-08-22

technetium 99m and Neoplasms

technetium 99m has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altai, M; Andersson, KG; Garousi, J; Löfblom, J; Mitran, B; Orlova, A; Oroujeni, M; Steinhardt, X; Tolmachev, V; Vorobyeva, A1
Altai, M; Buijs, J; Chernov, V; Deyev, S; Garousi, J; Güler, R; Löfblom, J; Mitran, B; Orlova, A; Proshkina, G; Schulga, A; Tolmachev, V; Vorobyeva, A1

Other Studies

2 other study(ies) available for technetium 99m and Neoplasms

ArticleYear
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of
    Amino acids, 2018, Volume: 50, Issue:8

    Topics: Animals; Cell Line, Tumor; Chelating Agents; Cysteine; ErbB Receptors; Humans; Mice; Molecular Imaging; Molecular Probes; Neoplasm Transplantation; Neoplasms; Peptides; Recombinant Fusion Proteins; Technetium; Tissue Distribution

2018
Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.
    Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3

    Topics: Animals; Ankyrin Repeat; Ankyrins; Cell Line, Tumor; Female; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Neoplasms; Protein Binding; Radionuclide Imaging; Receptor, ErbB-2; Single Photon Emission Computed Tomography Computed Tomography; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays

2019